Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Rašiová, M; Schlager, O; Heiss, C; Brodmann, M; Mircea, Olinic, D; Boc, V; Buso, G; Belch, J; Mazzolai, L; Madaric, J.
Adverse reactions after intravascular iodinated contrast media administration and their management.
Vasa. 2024;
Doi: 10.1024/0301-1526/a001122
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Brodmann Marianne
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Endovascular interventions and diagnostic examinations using iodinated contrast media (ICM) are standard of care in current vascular medicine. Although ICM use is generally considered safe, it may be associated with adverse reactions, vary from minor disturbances to rare, but severe life-threatening complications. This position paper of European Society of Vascular Medicine integrates current knowledge and summarizes the key information related to the use of intravascular ICM, serving as recommendation on prevention and management of acute, late, and very late adverse reactions. It should help the health professionals in all fields of vascular medicine to make decisions in daily practice for safe use of contrast media.
- Find related publications in this database (Keywords)
-
Iodinated contrast media
-
hypersensitivity
-
chemotoxic reaction
-
contrast-associated acute kidney injury